F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones
Published inClinical nuclear medicine, vol. 33, no. 7, p. 469-471
Publication date2008
Abstract
Keywords
- Bone and Bones/radionuclide imaging
- Cell Proliferation
- Cell Transformation, Neoplastic
- Fatal Outcome
- Female
- Fibrous Dysplasia of Bone/diagnosis/radionuclide imaging
- Fluorodeoxyglucose F18/diagnostic use
- Humans
- Middle Aged
- Neoplasm Metastasis
- Pelvis/pathology/radionuclide imaging
- Positron-Emission Tomography/methods
- Radiopharmaceuticals/diagnostic use
- Sarcoma/diagnosis
Citation (ISO format)
BERREBI, Olivier et al. F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones. In: Clinical nuclear medicine, 2008, vol. 33, n° 7, p. 469–471. doi: 10.1097/RLU.0b013e3181779259
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:1172
- DOI : 10.1097/RLU.0b013e3181779259
- PMID : 18580231
Additional URL for this publicationhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=N&PAGE=fulltext&AN=00003072-200807000-00004&LSLINK=80&D=ovft
Journal ISSN0363-9762
